Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stefania Morganti, M.D.

Concepts (110)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms192025211621.190 Why?
High-Throughput Nucleotide Sequencing2201936670.520 Why?
Pharmacogenetics120196820.470 Why?
Receptor, erbB-29202425980.410 Why?
Immunoconjugates320259760.370 Why?
Drug Resistance, Neoplasm4202553300.370 Why?
Neoplasms82024223500.320 Why?
Data Interpretation, Statistical1201826940.310 Why?
BRCA2 Protein220248020.310 Why?
BRCA1 Protein2202411550.280 Why?
Antineoplastic Agents72024136440.250 Why?
Immunotherapy6202447470.230 Why?
Receptors, Estrogen2202322520.230 Why?
Epirubicin12022820.210 Why?
Genomics1201859220.200 Why?
Clinical Trials, Phase III as Topic320208780.190 Why?
Receptors, Fibroblast Growth Factor120211930.180 Why?
Phthalazines120233970.180 Why?
Female2420253965320.160 Why?
Receptors, Progesterone1202311590.150 Why?
Protein Kinase Inhibitors3202456900.140 Why?
Fluorouracil1202216520.140 Why?
Bone Resorption120217210.140 Why?
Prognosis52024299590.140 Why?
Antineoplastic Combined Chemotherapy Protocols62025118760.140 Why?
Humans3220257668120.140 Why?
Cyclophosphamide1202222340.140 Why?
Ketones120171830.130 Why?
Furans120171990.130 Why?
Proto-Oncogene Proteins c-akt1202424560.130 Why?
Fibroblast Growth Factors120218710.120 Why?
Disease-Free Survival2202268530.120 Why?
Lymphocytes, Tumor-Infiltrating1202111050.120 Why?
Clinical Trials, Phase II as Topic320246380.120 Why?
Germ-Line Mutation1202318860.120 Why?
Neoplasms, Second Primary1202210620.120 Why?
Carcinoma, Intraductal, Noninfiltrating120219340.120 Why?
Neoplasm Recurrence, Local2202394070.110 Why?
Carcinoma, Ductal, Breast1202110970.110 Why?
Chemotherapy, Adjuvant1202235520.110 Why?
Immunologic Factors1202315940.110 Why?
Diagnostic Tests, Routine120187880.100 Why?
Neoplasm Metastasis5202148920.100 Why?
History, 21st Century1201815740.100 Why?
Carcinoma, Non-Small-Cell Lung2202053890.100 Why?
Tumor Microenvironment2202139420.090 Why?
Clinical Trials, Phase I as Topic220243290.090 Why?
Recurrence1202385070.090 Why?
Adiposity1202118920.090 Why?
History, 20th Century1201827640.090 Why?
Bone Neoplasms1202125610.080 Why?
Randomized Controlled Trials as Topic32020103840.080 Why?
Mutation32024302140.080 Why?
Medical Oncology1202023400.070 Why?
Neoplasm Staging22020112180.070 Why?
Immunohistochemistry12021110620.070 Why?
Prevalence12024158350.070 Why?
Lung Neoplasms22020134890.060 Why?
Case-Control Studies12023222480.060 Why?
Treatment Outcome42024652860.060 Why?
Aged, 80 and over32024595480.060 Why?
Adult620242233050.050 Why?
Risk Assessment22022242990.050 Why?
Body Mass Index12021130500.050 Why?
Research Design1201862060.050 Why?
Neoadjuvant Therapy2202429020.050 Why?
Disease Progression12018136420.050 Why?
Camptothecin120255990.050 Why?
Aged620241713440.050 Why?
Middle Aged720242232670.050 Why?
Drug Synergism1202417570.040 Why?
Immunotoxins120201750.040 Why?
Organ Specificity1202419680.040 Why?
Molecular Targeted Therapy2202128230.040 Why?
Oxazoles120201980.040 Why?
Young Adult22024599390.040 Why?
Antibodies, Monoclonal3202092440.040 Why?
Prospective Studies12024548720.040 Why?
Cell Death1202416760.040 Why?
Obesity12021130900.040 Why?
Lymphocyte Count120207940.040 Why?
Xenograft Model Antitumor Assays1202436050.030 Why?
Survival Rate22021128260.030 Why?
Retreatment120175980.030 Why?
Retrospective Studies52024816570.030 Why?
Histone Deacetylase Inhibitors120207770.030 Why?
Drug Therapy, Combination1202463060.030 Why?
Quinazolines1202013670.030 Why?
Drug Discovery1202110650.030 Why?
Breast1202119720.030 Why?
Lymphocytes1202026060.030 Why?
Cancer Vaccines1202010420.030 Why?
Biopsy1202467790.020 Why?
Pyridines1202028880.020 Why?
Cell Line, Tumor12024170890.020 Why?
Quality of Life22021134760.020 Why?
Neutrophils1202037820.020 Why?
Age Factors12024183970.020 Why?
Cell Differentiation12024116570.020 Why?
Kaplan-Meier Estimate1201765140.020 Why?
Cell Proliferation12021104510.020 Why?
Animals320241689390.020 Why?
Gene Expression Regulation, Neoplastic1202186230.020 Why?
Clinical Trials as Topic1202080450.010 Why?
Male320243641540.010 Why?
Algorithms12020140730.010 Why?
Time Factors12021401490.010 Why?
Signal Transduction12021236180.010 Why?
Mice12024818980.010 Why?
Risk Factors12021748890.010 Why?
Morganti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (110)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.